This finding confirmed data from the newest meta-analyses based on pooled studies, including 17,174 individuals 45 years of age or older participating in 6 population-based cohort studies, 2 clinic-based studies and 1 case‐control study, demonstrating that CFH risk variants are the leading drivers of late forms of AMD [60,61]. This evidence concerns the gene CFH and age-related macular degeneration.